Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.
Journal: Cancer research communications
Published: February 12, 2025
Pilot phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors.
Pilot phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors.
Journal: International journal of cancer
Published: September 17, 2024
Correction: Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 05, 2024
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
Journal: Oncoimmunology
Published: January 03, 2024
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 03, 2022
Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC).
Journal: British journal of cancer
Published: January 28, 2022
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies.
Journal: Journal for immunotherapy of cancer
Published: January 08, 2022
ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 17, 2021
Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid Tumors.
Journal: Frontiers in oncology
Published: September 29, 2021
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors.
Journal: Molecular cancer therapeutics
Published: July 30, 2021
Last Updated: 09/26/2026